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Prevalence and Heritabil ity of Symptomatic Syringomyelia
in Cavalier King Charles Spaniels and Long-term Outcome
in Symptomatic and Asymptomatic Littermates
M.S. Thøfner, C.L. Stougaard, U. Westrup, A.A. Madry, C.S. Knudsen, H. Berg, C.S.E. Jensen,
R.M.L. Handby, H. Gredal, M. Fredholm, and M. Berendt
Background: Syringomyelia (SM) is common in the Cavalier King Charles Spaniel (CKCS). Dogs with syringes express
clinical signs or might be clinically silent.
Objectives: To investigate the prevalence and heritability of symptomatic SM, the association between clinical signs
and magnetic resonance imaging (MRI) ﬁndings, and long-term outcome.
Animals: All CKCS registered in the Danish Kennel Club in 2001 (n = 240).
Methods: A cross-sectional questionnaire-based prevalence study validated by telephone interviews and clinically inves-
tigated clinical signs of SM. Dogs were 6 years at the time of investigation. A prospective observational litter study includ-
ing clinical investigations, MRI and 5-year follow-up of symptomatic and asymptomatic siblings. Heritability was
estimated based on the scale of liability in the study population and litter cohort.
Results: The cross-sectional study estimated a prevalence of symptomatic SM at 15.4% in the population. Thirteen
symptomatic and 9 asymptomatic siblings participated in the litter study. Spinal cord syringes were conﬁrmed in 21 of 22
littermates (95%). Syrinx diameter and mean syrinx : spinal cord ratio were signiﬁcantly correlated with clinical signs
(P < .01). Estimated heritability of symptomatic SM was 0.81. Symptomatic SM motivated euthanasia in 20%. Dogs with
syringes, which expressed no clinical signs at the age of 6, remained asymptomatic in 14/15 cases (93%).
Conclusions and Clinical Importance: The prevalence of symptomatic SM is high and genetics have a high impact on
clinical disease expression. Further investigations of factors inﬂuencing the outbreak threshold of clinical signs of SM are
desirable.
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Syringomyelia (SM) is a neurologic condition occur-ring in a hereditary form in the Cavalier King
Charles Spaniel (CKCS), the Griﬀon Bruxellois, in
other toy brachycephalic breeds as well as in
humans.1–4 The prevalence of SM in the CKCS has
not been estimated because of a lack of epidemiologic
studies investigating larger populations of dogs. SM is
characterized by the development of ﬂuid-ﬁlled cavities
(syringes) within the spinal cord parenchyma and is
associated with Chiari I malformation in humans and
Chiari-like malformation (CM) in the CKCS.2,5–11 The
pathophysiology of CM involves a decreased caudal
fossa volume with overcrowding of the craniocervical
junction and caudal descend of the cerebellum into or
through the foramen magnum.5–15 The pathogenesis of
syrinx formation and the association between CM and
SM is not fully understood, but it is believed that a
multifactorial etiology including a local obstruction of
the subarachnoidal space and abnormal cerebrospinal
ﬂuid dynamics are involved.5,10,12,16–19 Syringes are
predominantly found in the cervical region of the
spinal cord, but can form in multiple locations.20
In humans, the SM-associated damage to nocicep-
tive and other sensory pathways of the spinal cord,
causes pain to be a prominent feature in 50–90% of
adult patients.9,21,22 Other common clinical characteris-
tics in humans with SM include dermatomal patterns
of mixed loss of thermal sensitivity and paradoxical
association of hypersensitivity as well as trophic
changes with hyperhidrosis, glossy skin, coldness, and
From the Department of Veterinary Clinical and Animal
Sciences, University of Copenhagen, Frederiksberg C, Denmark
(Thøfner, Stougaard, Westrup, Madry, Knudsen, Berg, Jensen,
Handby, Gredal, Fredholm, Berendt).
The study was conducted at the Department of Veterinary Clini-
cal and Animal Science, University of Copenhagen, Denmark.
Poster presentation of preliminary results at the ECVN/ESVN
26th Symposium, September 26–28th 2013, Paris.
Corresponding author: M.S. Thøfner, Department of Veterinary
Clinical and Animal Sciences, Faculty of Health and Medical Sci-
ences, University of Copenhagen, Dyrlægevej 16, 1870 Frederiks-
berg C, Denmark; e-mail: mast@sund.ku.dk.
Submitted May 9, 2014; Revised August 13, 2014; Accepted
September 3, 2014.
Copyright © 2014 by the American College of Veterinary Internal
Medicine
10.1111/jvim.12475
Abbreviations:
CKCS Cavalier King Charles Spaniel
CM chiari-like malformation
DICOM digital imaging and communications in medicine
DKC Danish Kennel Club
DVCAS Department of Veterinary Clinical and Animal
Sciences
FOV ﬁeld of view
MRI magnetic resonance imaging
NEX number of excitations
NSAIDs nonsteroidal anti-inﬂammatory drugs
OME otitis media with eﬀusion
SE spin echo
SM syringomyelia
T1 and T2W T1 and T2 weighted
TE time to echo
TR time to repeat
TSE turbo spin echo
J Vet Intern Med 2015;29:243–250
paleness in humans.9,23 Dogs with SM display charac-
teristic behaviors, such as phantom scratching, unwill-
ingness to be touched or groomed in the head and
neck region, and in severe cases, paroxysmal pain
manifestations with vocalization, intense scratching,
rubbing, and circling on the ﬂoor. In dogs with SM,
these behaviors have been associated with pain.16,24–26
CKCS with a magnetic resonance imaging (MRI)-con-
ﬁrmed syrinx might be asymptomatic.21 In symptom-
atic CKCS, a wide syrinx diameter and asymmetric
distribution of the syrinx aﬀecting the dorsal horn are
strong predictors of pain.25,27 Middle ear eﬀusion (hy-
perintense material within the tympanic bulla probably
analogous to otitis media with eﬀusion [OME] in
humans) is often present in the CKCS and may be
detected on T2-weighted MRI scans.28–30 The inci-
dence of OME in CKCS has been estimated to 32–
54%.28–31 It has been debated if some of the behaviors
associated with pain in CKCS could be related to
OME, but this however remains controversial.28,29,32,33
The heritability of SM has been estimated to be 0.37
based on MRI-conﬁrmed syrinx ﬁndings in a cohort of
384 CKCS, whereas the heritability of symptomatic
SM has not previously been investigated.1
The aim of this study was to estimate the prevalence
and heritability of symptomatic SM in Danish CKCS.
Furthermore, to investigate the association between
clinical signs and MRI ﬁndings and report long-term
outcome in a CKCS litter cohort including symptom-
atic and asymptomatic siblings.
Materials and Methods
The study was initiated in 2007, ﬁnalized in 2012, and con-
ducted at the Department of Veterinary Clinical and Animal Sci-
ences (DVCAS), University of Copenhagen, Denmark. The study
population consisted of all CKCS born and registered in the
Danish Kennel Club (DKC) in 2001. The DKC register lists dogs
chronologically by date of registration, and to obtain a DKC
studbook, dogs must be registered no later than 3 weeks after
birth. The study was conducted in 3 phases.
Definitions
In this paper, the terms “symptomatic” and “asymptomatic”
have been chosen for simplicity sake although the authors
acknowledge that “symptomatic” is a subjective term inappropri-
ate for animals. “Symptomatic” is here deﬁned as being indica-
tive of a speciﬁc disease (in this paper, the expression of clinical
signs of SM).
Phase I—Prevalence Study
A cross-sectional design was used to estimate the prevalence
of symptomatic SM. The study investigated clinical signs of SM
in the study population (n = 240). Dogs born in 2001 (>6 years
old) were chosen to secure that clinical signs of SM, if any,
would have had their debut at the time of investigation. The ﬁrst
contact to the owners was established with a mailed letter distrib-
uted by the DKC. A short introduction of the investigation was
accompanied by an invitation to answer an enclosed screening
questionnaire with dichotomous alternative questions along with
a semiopen component in which comments could be stated. The
questions addressed the following clinical signs indicating SM:
unilateral/bilateral episodic scratching of the head/neck region,
phantom scratching of the head/neck region (the paw does not
touch the skin), reluctance to tolerate touching and/or grooming
of the head/neck region and/or resists wearing a collar. Signs are
worsened if the dog becomes exited, agitated or both, and signs,
which may be interpreted as pain often associated with the neck
region.10,34 The owners were asked to return their answers to the
DKC in an enclosed stamped envelope along with a written con-
sent conﬁrming their participation and providing contact infor-
mation. Owners of dogs expressing at least one of the signs
listed, or who reported other clinical signs that could raise a sus-
picion of SM, were subsequently contacted by phone by the
investigators and enrolled in an interview. An extended standard-
ized questionnaire was used to provide further information and
validate the answers given in the screening questionnaire. The
telephone interview was performed by 2 investigators (CSEJ and
RMLH), supervised by 2 veterinary neurologists (HG and MB),
and the answers were subsequently scrutinized in collaboration
with a senior veterinary neurologist (MB). Dogs qualifying as
suspected symptomatic SM cases after validating telephone inter-
view were invited to participate in a clinical investigation at the
DVCAS Companion Animal University Hospital, including clini-
cal and neurologic examination and standard hematology, bio-
chemical, and thyroid proﬁles. Based on the deﬁnition of
“symptomatic” as being indicative of a speciﬁc disease (in this
case SM),35 a ﬁnal evaluation procedure served to deﬁne (clinical)
symptomatic SM cases. The evaluation procedure included the
clinical signs reported by the owners subsequently conﬁrmed by
the investigators and supported by the results of the clinical
investigation (focused on excluding possible diﬀerential
diagnosis).
Phase II—Litter Cohort Study
Eight litters were selected for further investigation of the asso-
ciation between clinical signs and MRI ﬁndings, based on pedi-
gree information and the criteria that at least 1 sibling had been
identiﬁed as a symptomatic SM case in the prevalence study. The
owners were contacted by phone and interviewed using an
extended standardized questionnaire addressing signs of SM to
report the clinical status of the dogs at the time of inclusion. All
dogs were invited to participate in the clinical investigation
including an oral investigator-owner interview, clinical and neu-
rologic examination, standard hematology, biochemical and thy-
roid proﬁles, and MRI of the brain and cervical spinal cord (C1–
T1). Dogs presenting with a heart murmur were further evaluated
with ECG and echocardiography.
Magnetic resonance imaging scans were performed using a 0.2
Tesla Esaote Vet-scan. The standardized protocol included T1-
weighted sagittal images of the neurocranium and cervical spinal
cord (C1–C3) (T1-spin echo [SE] with a ﬁeld of view [FOV] of
14 cm, time to echo [TE] of 18 milliseconds, time to repeat [TR]
of 480–560 milliseconds, slice thickness 4 mm, a slice gap of
0.4 mm, and a number of excitations [NEX] of 3), T1-weighted
transverse SE sequences (FOV: 14 cm, TE: 18 milliseconds, TR:
930 milliseconds, slice thickness 5 mm, slice gap: 0.5 mm and
NEX: 3) of the neurocranium, T2-weighted sagittal sequences
(high resolution turbo spin echo [TSE], FOV 14 cm, TE: 80 milli-
seconds, TR: 2,800 milliseconds, slice thickness 4 mm, a slice gap
of 0.4 mm and NEX: 2) and T2-weighted transverse TSE
sequences (FOV 14 cm, TE: 80 milliseconds, TR: 2,800–
2,820 milliseconds, slice thickness 5 mm, a slice gap of 0.5 mm
and NEX: 2) of the neurocranium and cervical spinal cord (C1–
C3). T1 and T2 matrix: 256 9 256. The dogs were placed in ster-
nal recumbency, and the total examination time per patient was
75 minutes. Scans were transferred to the web-based DICOM
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image viewing system RemoteEye,a blinded and subsequently
evaluated individually by 2 investigators (CSK & HB) and addi-
tionally by an experienced veterinary radiologist (UW).
T2 weighted images were used for syrinx measurements. A syr-
inx was deﬁned as a ﬂuid-ﬁlled cavity in the parenchyma with a
diameter ≥2 mm within the spinal cord. A presyrinx was deﬁned
as edema in the spinal cord with a lesion diameter <2 mm with
or without central canal dilatation. A SM-positive case was
deﬁned as a CKCS with a MRI-conﬁrmed syrinx. Descriptive
data included syrinx diameter, cranial limit of the syrinx, distri-
bution of the syrinx (symmetric or asymmetric), and spinal cord
diameter. The syrinx : spinal cord ratio was calculated. If more
than 1 syrinx was detected, only the largest was used in the cal-
culations. The hypothesis of no association between the expres-
sion of clinical signs and the presence of a syrinx was tested
using Fisher’s exact test. The hypotheses of no association
between the expression of clinical signs and (1) syrinx diameter
and (2) syrinx : spinal cord ratio were tested using Student’s t-
tests. Data were analyzed by the statistical software in Excel,b
P < .05 was considered signiﬁcant. It was recorded if CM, ﬁnd-
ings consistent with otitis media with eﬀusion (OME), or both
were present. CM was diagnosed when cerebellar indentation
caused by the supraoccipital bone with or without cerebellar her-
niation into or through the foramen magnum was identiﬁed. In
addition, it was recorded if the investigators initiated treatment
after the clinical and MRI investigations. In 2007, the treatment
used would typically be NSAIDs and/or furosemide (Furixc)
alone or in combination and in grave cases, furosemide and pred-
nisolone (Prednisolon DAKc).
Estimation of Heritability. The scale of liability (standard devi-
ation from threshold) in the 2 populations described in phase I
and II were used for the estimation of heritability according to
methods described for threshold characters.36 The applet avail-
able at http://www.ihh.kvl.dk/htm/kc/popgen/genetik/applets/
heritt.htm was used for the calculations.
Phase III—5-year Follow-up (2012)
A follow-up telephone interview was conducted in autumn
2012 with the purpose of investigating long-term outcome for the
now 11-year-old siblings participating in the 2007 litter cohort.
The telephone interview was performed by 1 investigator (CLS)
and supervised by a senior veterinary neurologist (MB) to secure
a standardized interview. A standardized questionnaire was used
to collect data regarding the status of the dogs including infor-
mation addressing alive/deceased, possible clinical signs, possible
progression or remission of clinical signs, development of new
clinical signs since 2007, treatment, and for deceased dogs, time
and cause of death.
Results
Phase I—Prevalence Study
Of 240 owners contacted by mail, 134 responded,
giving a response rate of 56% (Fig 1A). Eleven
responders were excluded (6 because the dogs were
euthanized before the age of 3, and 5 dogs where ques-
tionnaires were returned incomplete), leaving 123 dogs
(61 females and 62 males) to be included in the investi-
gation. Nineteen owners reported 1 or more clinical
signs of SM in their dogs (positive responders),
whereas 104 owners reported that their dog expressed
no clinical signs of SM (negative responders). After
the subsequent telephone interview and validation pro-
cedure, the 19 dogs (positive responders) were
categorized as suspected symptomatic SM cases. Four-
teen owners agreed to let their dogs participate in the
clinical investigation, which revealed no other diagno-
sis than SM, which could explain the signs expressed,
by the dogs. Five dogs did not participate in the clini-
cal investigation, but were evaluated to be symptom-
atic SM cases based on the expression of multiple
signs known to be associated with SM,16,19,24,37 and
where the owners reported that there had been no clin-
ical ﬁndings related to possible diﬀerential diagnosis
such as eg, skin disease, ear infection, etc. Thus, based
on the clinical signs reported and conﬁrmed by the
investigators, and the results of the clinical investiga-
tion, 19 dogs (11 females and 8 males) were ﬁnally
included as symptomatic SM cases. The estimated
prevalence of symptomatic SM in 6-year-old Danish
CKCS born in 2001 was 15.4% (19/123), CI0.95 [9; 22].
Phase II—Litter Cohort Study
Eight litters were selected for further investigation
based on the criteria that at least 1 sibling had been
identiﬁed as a symptomatic SM case in the prevalence
study. The 8 litters comprised a total of 35 dogs
(Fig 1B). Seventeen dogs expressed clinical signs of
SM, whereas 17 dogs expressed no signs of SM. One
dog was excluded as it had been euthanized at the age
of 15 weeks because of severe seizures.
Twenty-two of 34 dogs (63%), including 11 dogs
identiﬁed as symptomatic SM cases in the prevalence
study, were allowed by the owners to participate in full
clinical work-up including MRI. Ten owners declined
to let their dogs participate in the MRI investigation,
primarily because of concerns associated with anesthe-
sia. One 5-year-old dog had been euthanized the year
before because of expression of severe signs consistent
with SM and could therefore not be investigated, and
the investigators excluded 1 dog because of severe
heart disease.
Thirteen of the 22 dogs (59%) were classiﬁed as
symptomatic SM cases, whereas 9 dogs displayed no
clinical signs of SM. MRI scans, however, revealed
syringes in the cervical spinal cord in 21 of 22 dogs
(95%); the remaining dog (expressing no clinical signs
of SM) had a presyrinx (Table 1). Thus, the MRI
investigation revealed that 8 dogs were clinically silent
(asymptomatic SM-positive cases), although having a
syrinx.
There was no statistical association between expres-
sion of clinical signs and the presence of syringes
(P = .41). A positive predictive value of the MRI scan
was calculated to 0.62 (the probability that a dog
would express clinical signs if it had a syrinx). Syrinx
diameter and syrinx : spinal cord ratio was evaluated
on T2W transverse sequences in 19 dogs. Two dogs
were excluded because the MRI studies were incom-
plete. The syrinx diameter varied from 0.3 to 0.8 cm.
The total mean of the maximum syrinx diameter was
0.55 cm. The mean maximum syrinx diameter was
0.63 cm in symptomatic dogs and 0.4 cm in asymp-
tomatic dogs. The data demonstrated that
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Fig 1. (A) Flow diagram, prevalence study—study phase I. aSix responders excluded because of euthanazia of the dogs before the age
of 6, 5 because of incomplete questionnaires. bSixty-one females and 62 males. cClinical signs reported by the owners, validated on sub-
sequent telephone interview. (B) Flow diagram, litter cohort study—study phase II. aIdentiﬁed in study phase I (of all eligible Danish
CKCS born in 2001). bExcluded because of euthanazia in 2001. cIncluding 11 dogs identiﬁed and validated in study phase I. dTen dogs
excluded because of reluctant owners, 1 because of euthanazia, 1 because of severe heart disease. (C) Flow diagram of the 2012 long-
term follow-up study—study phase III. aTwo owners declined to participate, 1 answer was excluded.
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symptomatic dogs had a signiﬁcantly wider syrinx
diameter than asymptomatic dogs (P < .01). The total
mean syrinx : spinal cord ratio was 0.58. Symptomatic
dogs had a signiﬁcantly greater mean syrinx : spinal
cord ratio (0.66), when compared to asymptomatic
dogs, which had a mean syrinx : spinal ratio of 0.43
(P < .01). The cranial limit of the syrinx was C2 in 17
of the 21 dogs (81%), C3 in 3 dogs (14%), and C1 in
1 dog (5%). Syrinx asymmetry (ie, unilateral dorsolat-
eral deviation of the cavity) was observed in 6 (5
symptomatic and 1 asymptomatic) dogs. Fisher’s exact
test of the association between symmetry versus asym-
metry and expression of clinical signs (yes/no) was
nonsigniﬁcant (P = .19). CM was identiﬁed in 22 of 22
dogs (100%). OME was present in 11 dogs (5 symp-
tomatic and 6 asymptomatic SM cases).
Estimation of Heritability. Heritability of symptom-
atic SM in dogs >6 years of age was calculated using
information on diﬀerence in mean liability within the
population and within related individuals to an
aﬀected animal, respectively.36 Using the data pre-
sented (Table 2), the heritability was calculated at
0.81. In support of the high heritability, the diﬀerence
between prevalence of symptomatic SM in the popula-
tion and in the ones that were related to an aﬀected
full sibling was statistically signiﬁcant (chi-
square = 9.3; df = 1; P < .05).
Phase III—5-year Follow-up (2012)
Thirty-one of 34 dogs from the 2007 litter cohort
(16 symptomatic and 15 asymptomatic dogs) partici-
pated in follow-up in 2012, where the dogs were
11 years old (Fig 1C). Two owners declined and 1 dog
was excluded because of an incomplete interview.
Eleven of the 31 dogs (35%) were alive, while 20
(65%) had been euthanized. Euthanasia was directly
related to signs of SM in 4 dogs (20%). Thirteen of 16
symptomatic dogs remained symptomatic during the
study period (Table 3A). With respect to expression of
signs, 4 dogs experienced progression, 5 dogs remained
status quo, 4 dogs experienced regression (3 with treat-
ment) and 3 dogs became asymptomatic (1 with treat-
ment) during the study period. Fourteen of 15
asymptomatic dogs remained asymptomatic during the
study period, whereas 1 dog (with a MRI-conﬁrmed
syrinx in 2007) developed clinical signs of SM from
2007 to 2012.
When evaluating the 22 dogs participating in the
clinical and MRI investigation in 2007 separately, the
following results were obtained (Table 3B): Twenty of
22 dog owners participated in the 2012 follow-up,
including 11 symptomatic SM cases and 9 asymptom-
atic SM cases (8 dogs with a MRI-conﬁrmed syrinx
and 1 dog with a presyrinx). Ten of 11 symptomatic
SM cases remained symptomatic, whereas 1 previously
symptomatic SM case became asymptomatic during
the study period (without treatment). With respect to
the expression of clinical signs in the 10 dogs, which
remained symptomatic, 4 dogs deteriorated, 3 dogs
remained status quo, and 3 dogs improved (with treat-
ment) during the study period. Eight of 9 asymptom-
atic SM cases remained asymptomatic, whereas 1 dog
developed clinical signs of SM during the study period.
Discussion
This study estimated a prevalence of 15.4% of
symptomatic SM in Danish CKCS born in 2001
(>6 years old) and demonstrated that genetic factors
strongly inﬂuence the clinical expression of SM.36 The
study furthermore reported that only a minority of
asymptomatic dogs with a MRI-conﬁrmed syrinx at
6 years develop clinical signs later in life.
Table 1. MRI ﬁndings in 22 dogs participating in the litter cohort study.
In All CKCS
(n = 22)
In Asymptomatic
SM Cases (n = 9)
In Symptomatic
SM Cases (n = 13) P-Value
Syrinx present/total (%) 21/22 (95) 8/9 (89) 13/13 (100)
Syrinx diameter T2W (cm), mean (range) 0.55 (0.3–0.8) 0.4 (0.3–0.8) 0.63 (0.3–0.8) .01
Spinal cord diameter (cm), mean (range) 0.94 (0.7–1.1) 0.9 (0.8–1.0) 0.96 (0.7–1.1) .08
Syrinx : spinal cord ratio, mean (range) 0.58 (0.3–0.86) 0.43 (0.3–0.8) 0.66 (0.33–0.86) .01
Asymmetric syrinx/total (%) 6/21 (29) 1/8 (13) 5/13 (38) .19
Cerebellar herniation/total (%) 21/21 (100) 8/8 (100) 13/13 (100)
MRI, magnetic resonance imaging; CKCS, Cavalier King Charles Spaniel; SM, syringomyelia; T2W, T2 weighted.
Table 2. Prevalence of symptomatic syringomyelia used for heritability estimation.
No. Non-aﬀected Individuals No. Aﬀected Individuals Frequency
In the population 104 19 0.1544
In full sib families 17 9a 0.3461
In remaining populationb 87 10 0.1031
aThe 9 individuals represent the 17 aﬀected dogs minus the 8 index cases/propositus used for the selection of the families.
bUsed for calculation of chi-square.
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The dogs under investigation were older than
6 years of age, which served to secure that clinical
signs of SM would have evolved at the time of inclu-
sion. For a cross-sectional study based on mailed ques-
tionnaires, a response rate of 56% is considered to be
good.38 It is possible that the prevalence estimate is
biased by the fact that owners with experience of SM
might be more inclined to reply, whereas others may
neglect signs of SM. Had all 240 owners returned the
mailed questionnaire and had no new symptomatic
cases been identiﬁed; the minimum prevalence had
been 7.9% (19/240). The prevalence estimate was
based on owner-reported clinical signs of SM, a tele-
phone validation procedure, and a clinical evaluation,
which served to further conﬁrm the presence of clinical
signs and rule out potential diﬀerential diagnosis. Five
of the 19 dogs, which contributed to the prevalence
estimate, did not participate in the clinical evaluation,
and although nothing in the dogs’ history indicated
other diagnosis than SM, this is a weakness to the
study, as we cannot exclude that some dogs were
included as false-positive cases. However, 11 of the 19
dogs (60%) which participated both in the prevalence
study and litter cohort study all had a MRI-conﬁrmed
syrinx and this supports that the dogs which expressed
clinical signs of SM were true SM cases.
This study identiﬁed a substantial number of clini-
cally silent dogs although having a syrinx and having
symptomatic littermates. Symptomatic SM cases had a
signiﬁcantly greater syrinx diameter and a larger syr-
inx : spinal cord ratio compared to the group of
asymptomatic SM cases which conﬁrms previous
reports.25
Our data allowed us to estimate heritability of the
expression of symptomatic SM in CKCS 6 years of age,
which has not previously been done. The heritability of
SM diagnosed by a single MRI diagnosis without fol-
low-up on clinical status has been estimated at 0.37,1
whereas heritability of symptomatic SM was estimated
at 0.81 in this study. It is apparent that the development
of a syrinx does not always result in a clinical expres-
sion of signs of SM, and thus there may not be a dis-
crepancy between these results. Although the
heritability estimate for symptomatic SM might be an
overestimation because of the fact that there is a poten-
tial bias in the prevalence study (dog owners with
aﬀected dogs might be more inclined to participate), the
heritability is clearly very high. Per deﬁnition heritabil-
ity is measured by estimating the relative contribution
of genetic and nongenetic diﬀerences to the total pheno-
typic variation in a population.36 The estimated herita-
bility of symptomatic SM indicates that genetics explain
most of the total phenotypic variance in the population.
As this study found an equal number of symptom-
atic and asymptomatic dogs with OME, and CM was
conﬁrmed in all MRI scanned dogs, it was not possible
to examine if CM, OME alone, or both could have
contributed to some of the clinical signs reported by
the owners.
Finally, we acknowledge that the results of this
study are aﬀected by the drawbacks inevitably associ-
ated with epidemiologic and clinical studies, where it is
seldom possible to motivate all owners to allow their
dogs to participate in all planned procedures. It lies
within the design of the study that all dogs should
undergo the same standardized investigations as
described in details in the materials and methods sec-
tion. Being an epidemiologic study where the investiga-
tors did contact the owners, we must however respect
that in some cases, owners do not want to participate
in full work-up. In that case, the investigators must
thoroughly determine for each dog if it can be deﬁned
as a true case based on the collected information. We
also acknowledge that some of the choices made in
2007 regarding the study design may have inﬂuenced
the results, eg, that measuring syrinx size on T2W
images obtained from a low ﬁeld system was subopti-
mal.39 MRI identiﬁcation of a syrinx is presently the
gold standard for diagnosing SM. The results of this
study provides information which necessitate further
examination of factors contributing to disease expres-
sion and progression, and to the threshold of outbreak
of clinical signs.
Conclusions
This study of Danish CKCS estimated a high preva-
lence of symptomatic SM and found a high impact of
Table 3. Long-term outcome in (A) 34 and (B) 22 symptomatic and asymptomatic siblings identiﬁed in the 2007-
litter cohort study.
2007
2012
Status Quo Deterioration Improvement Unknown
A
Symptomatic SM cases 17 5 4 7a 1
Asymptomatic SM cases 17 14 1b 2
B
Symptomatic SM cases 12 3 4 4c 1
Asymptomatic SM cases 10 8 1b 1
aThree dogs changed status from symptomatic to asymptomatic.
bOne dog changed status from asymptomatic to symptomatic.
cOne dog changed status from symptomatic to asymptomatic.
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genetics on the clinical expression of the disease. Dogs
with a MRI-conﬁrmed syrinx and clinical signs are at
risk of euthanasia, whereas dogs with a MRI-con-
ﬁrmed syrinx which are asymptomatic by the age of 6,
seem to have a good chance of never developing such
signs. It is of interest to conduct further studies investi-
gating factors, which may inﬂuence the threshold of
outbreak of clinical signs of SM.
Footnotes
a See: http://www.neologica.it/html/RemotEye.php
b Microsoft Excel 2008 for Mac Version 12.3.6
c Takeda Pharma A/S, Langebjerg 1, DK-4000 Roskilde, Den-
mark
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